Mast Cells, T Cells, and inhibition by luteolin: Implications for the pathogenesis and treatment of multiple sclerosis

Advances in Experimental Medicine and Biology

Volumn 601, Issue , 2007, Pages 423-430

  Theoharides, Theoharis C ^a   Kempuraj, Duraisamy ^a   Iliopoulou, Betina P ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; FLAVONOID; LUTEOLIN;

BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; CHEMICAL MODEL; CHEMISTRY; CYTOLOGY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAST CELL; MULTIPLE SCLEROSIS; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIGENS, CD28; ANTIGENS, CD3; FLAVONOIDS; HUMANS; LUTEOLIN; LYMPHOCYTE ACTIVATION; MAST CELLS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; MULTIPLE SCLEROSIS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 34848834581     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72005-0_45     Document Type: Conference Paper

References (49)

1. Aktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N.E., Lauster, R., Kloetzel, P.M., Infante-Duarte, C., Brocke, S. and Zipp, F. (2004) Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 173, 5794-5800.
2. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M.L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P.S., Martin, R., McFarland, H.F. and Trent, J.M. (2003) Gene expression profile in multiple sclerosis patients and healthy controls: Identifying pathways relevant to disease. Hum. Mol. Genet. 12, 2191-2199.
3. Brill, A., Baram, D., Sela, U., Salamon, P., Mekori, Y.A. and Hershkoviz, R. (2004) Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro. Clin. Exp. Allergy 34,1725-1731.
4. Brown, M.A., Tanzola, M. and Robbie-Ryan. M. (2002) Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38:1373-1378.
5. Dery, O., Corvera, C.U., Steinhoff, M. and Bunnett, N.W. (1998) Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-C1452.
6. Dietsch, G.N. and Hinrichs, D.J, (1991) Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135, 541-548.
7. Duthie, S.J., Johnson, W. and Dobson, V.L. (1997) The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat. Res. 390, 141-151.
8. Esposito, P., Chandler, N., Kandere-Grzybowska, K., Basu, S., Jacobson, S., Connolly, R., Tutor, D. and Theoharides, T.C. (2002) Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303, 1061-1066.
9. Foreman, J.C. (1984) Mast cells and the actions of flavonoids. J. Allergy Clin. Immunol. 73, 769-774.
10. Galli, S.J. (1990) New insights into "the riddle of the mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62, 5-33.
11. Galli, S.J., Nakae, S. and Tsai, M. (2005) Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135-142.
12. Goldn, R. (2007) Towards individualized multiple sclerosis therapy. Lancet Neurol. 4, 693-694.
13. Gregory, G.D., Raju, S.S., Winandy, S. and Brown. M.A.(2006) Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE. J. Clin. Invest. 116, 1327-1336.
14. Halliwell, B. (2001) Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716.
15. Hendriks, J.J., Alblas, J., van der Pol, S.M., van Tol, E.A., Dijkstra, C.D. and de Vries, H.E. (2004) Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J. Exp. Med. 200, 1667-1672.
16. Herrmann, K. (1976) Flavonols and flavones in food plants. J. Food Technol. 11, 433-448.
17. Hirano, T., Higa, S., Arimitsu, J., Naka, T., Ogata, A., Shima, Y., Fujimoto, M., Yamadori , T., Ohkawara, T., Kuwabara, Y., Kawai, M., Matsuda, H., Yoshikawa M., Maezaki, N., Tanaka, T., Kawase, I. and Tanaka, T. (2006) Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem. Biophys. Res. Commun. 340, 1-7.
18. Ibrahim, M.Z.M., Reder, A.T., Lawand, R., Takash, W. and Sallouh-Khatib, S. (1996) The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70, 131-138.
19. Johnson, D., Seeldrayers, P.A. and Weiner, H.L. (1988) The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 444, 195-198.
20. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O.A.R., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K. and Akdis, C.A. (2001) Histamine regulates T cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425.
21. Kandere-Grzybowska, K., Kempuraj, D., Cao, J., Cetrulo, C.L. and Theoharides, T.C. (2006) Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br. J. Pharmacol.148, 208-215.
22. Kempuraj, D., Madhappan, B., Christodoulou, S., Boucher, W., Cao, J., Papadopoulou, N., Cetrulo, C.L. and Theoharides, T.C. (2005) Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol. 145, 934-944.
23. Kimata, M., Inagaki, N. and Nagai, H. (2000) Effects of luteolin and other flavonoids on IgEmediated allergic reactions. Planta Med. 66, 25-29.
24. Krüger, P.G. (2001) Mast cells and multiple sclerosis: A quantitative analysis. Neuropathol Appl. Neurobiol. 27, 275-280.
25. Lassmann, H. and Ransohoff, R.M. (2004) The CD4-Th1 model for multiple sclerosis: A crucial re-appraisal. Trends Immunol. 25, 132-137.
26. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S.J., Oksenberg, J.R., Raine, C.S., Heller, R. and Steinman, L. (2002) Genemicroarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
27. Lu, F., Selak, M., O'Connor, J., Croul, S., Lorenzana, C., Butunoi, C. and Kalman, B. (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177, 95-103.
28. Macey, M.G., Hou, L., Milne, T., Parameswaren, V., Howe, D., Cavenagh, J.D., Howells, G.L. and Newland, A.C. (1998) A CD4+ proliferation of large granular lymphocytes expresses the protease activated receptor-1. Br. J. Haematol. 101, 78-81.
29. Malamud, V., Vaaknin, A., Abramsky, O., Mor, M., Burgess, L.E., Ben-Yehudah, A. and Lorberboum-Galski, H. (2003) Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6 and IL-1 beta: Possible relevance to multiple sclerosis. J. Neuroimmunol. 138, 115-122.
30. Martino, G., Furlan R. and Poliani, P.L. (2000) [The pathogenic role of inflammation in multiple sclerosis]. Rev. Neurol. 30, 1213-1217.
31. Middleton, E., Jr. (1998) Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol. 439, 175-182.
32. Middleton, E., Jr., Kandaswami, C. and Theoharides, T.C. (2000) The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52, 673-751.
33. Minagar, A. and Alexander, J.S. (2003) Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9, 540-549.
34. Molino, M., Barnathan, E.S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., Hoxie, J.A., Schechter, N., Woolkalis, M. and Brass, L.F. (1997) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. 272, 4043-4049.
35. Nakae, S., Suto, H., Kakurai, M., Sedgwick, J.D., Tsai, M. and Galli, S.J. (2005) Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 102, 6467-6472.
36. Ott, V.L., Cambier, J.C., Kappler, J., Marrack, P. and Swanson, B.J. (2003) Mast celldependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 4, 974-981.
37. Pedotti, R., De Voss, J.J., Steinman, L. and Galli, S.J. (2003a) Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479-484.
38. Pedotti, R., DeVoss, J.J., Youssef, S., Mitchell, D., Wedemeyer, J., Madanat, R., Garren, H., Fontoura, P., Tsai, M., Galli, S.J., Sobel, R.A. and Steinman, L. (2003b) Multiple elementsof the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA 100, 1867-1872.
39. Redegeld, F.A. and Nijkamp, F.P. (2005) Immunoglobulin free light chains and mast cells: Pivotal role in T cell-mediated immune reactions? Trends Immunol. 24, 181-185.
40. Rozniecki, J.J., Hauser, S., Stein, M., Lincoln, R. and Theoharides, T.C. (1995) Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63-66.
41. Ruuls, S.R., Bauer, J., Sontrop, K., Huitinga, I., 't Hart, B.A. and Dijkstra, C.D. (1995) Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56, 207-217.
42. Salamon, P., Shoham, N.G., Gavrieli, R., Wolach, B. and Mekori, Y.A. (2005) Human mast cells release interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60, 1316-1319.
43. Smith, K.J. and McDonald, W.I. (1999) The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease. Philos. Trans. R Soc. Lond. B Biol. Sci. 1390, 1649-1673.
44. Stone, L.A., Smith, M.E., Albert, P.S., Bash, C.N., Maloni, H., Frank, J.A. and McFarland, H.F. (1995) Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: Relationship to course, gender, and age. Neurology 45, 1122-1126.
45. Tartaglia, L.A., Goeddel, D.V., Reynolds, C., Figari, I.S., Weber, R.F., Fendly, B.M. and Palladino, M.A., Jr. (1993) Stimulation of human T cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151, 4637-4641.
46. Theoharides, T.C. and Cochrane, D.E. (2004) Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146, 1-12.
47. Theoharides, T.C., Dimitriadou, V., Letourneau, R.J., Rozniecki, J.J., Vliagoftis, H. and Boucher, W.S. (1993) Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: Changes resembling early stages of demyelination. Neuroscience 57, 861-871.
48. Verbeek, R., Plomp, A.C., van Tol, E.A. and van Noort, J.M. (2004) The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem. Pharmacol. 68, 621-629.
49. Zappulla, J.P., Arock, M., Mars, L.T. and Liblau, R.S. (2002) Mast cells: New targets for multiple sclerosis therapy? J. Neuroimmunol. 131, 5-20.